Evaluation of the need for biopsy in a pediatric population with suspected Celiac clinical disease

The aim was to evaluate the diagnosis value of serological tests in a pediatric population with suspected celiac disease. In the serum of patients with classical symptoms, non-classical symptoms, or with an increased risk for celiac disease, antibodies anti–tissue transglutaminase IgA (a-tTG-IgA) an...

Full description

Bibliographic Details
Main Authors: López, Miryan S., Fermoselle, Gianninna, Manulak, María A., Sprang, Mónica D. R., Vinuesa, Fernando, Zapata, Pedro D., Negri, Gustavo A.
Format: Online
Language:Spanish
Published: Facultad de Ciencias Exactas, Químicas y Naturales 2017
Subjects:
Online Access:https://www.fceqyn.unam.edu.ar/recyt/index.php/recyt/article/view/206
Description
Summary:The aim was to evaluate the diagnosis value of serological tests in a pediatric population with suspected celiac disease. In the serum of patients with classical symptoms, non-classical symptoms, or with an increased risk for celiac disease, antibodies anti–tissue transglutaminase IgA (a-tTG-IgA) and IgG anti–deamidated gliadin peptide (a-DGP-IgG) were measured. Endoscopic biopsy was performed on 97 patients: 62 of them had Marsh 3 lesion (celiac disease confirmed), 7 had Marsh 2 lesion and the other 28, Marsh 0-1 lesion. A 100% of positive predictive value for a tTG-IgA ≥ 100 U ml, and 95% for a-DGP-IgG ≥ 100 U/ml were obtained. When both (tTG-IgA and a-DGP-IgG) were ≤ 10 U/ml, the negative predictive value was 100%. Values of a-tTG-IgA ≥ 100 U/ml allowed the diagnosis of celiac disease in the studied population. When a-tTG-IgA and a-DGP-IgG, were both ≤ 10 U/ml it ruled out celiac disease.